Resources Management Corp Biogen Inc. Transaction History

Resources Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $2,813 - $3,345	-15 Closed	0 $0
Q1 2022 May 20, 2022	SELL	$193.77 - $244.14 $3,875 - $4,882	-20 Reduced 57.14%	15 $3,000
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $12,147 - $14,231	-50 Reduced 58.82%	35 $10,000
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $13,203 - $18,244	-60 Reduced 41.38%	85 $25,000
Q3 2019 Dec 04, 2019	SELL	$217.44 - $243.88 $8,697 - $9,755	-40 Reduced 21.62%	145 $34,000

Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $54,299 - $71,008	185 New	185 $65,000

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Resources Management Corp , based on Form 13F filings with the SEC.

Stay updated on Resources Management Corp with notifications on news.